ArticleACR open rheumatology2025

Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study.

Soraya Benamar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.